Phio Pharmaceuticals Corp.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $21.0M | $5.4M | $8.5M | $11.8M | $24.1M | $14.3M | $7.0M | $14.9M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $21.5M | $5.7M | $9.3M | $12.4M | $24.7M | $15.2M | $7.3M | $15.2M |
| Property, Plant & Equipment | $11.0K | $2.0K | $6.0K | $183.0K | $133.0K | $157.0K | $210.0K | $172.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $21.5M | $5.7M | $9.4M | $12.8M | $25.2M | $15.7M | $8.0M | $15.3M |
| Liabilities | ||||||||
| Accounts Payable | $435.0K | $253.0K | $657.0K | $779.0K | $283.0K | $728.0K | $809.0K | $550.0K |
| Total Current Liabilities | — | $1.0M | $1.6M | $1.9M | $3.1M | $2.2M | $1.9M | $1.7M |
| Long-Term Debt | — | — | — | — | $0 | $231.0K | $0 | — |
| Total Liabilities | $1.3M | $1.0M | $1.6M | $2.0M | $3.2M | $2.7M | $2.3M | $1.7M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-155.1M | $-146.4M | $-139.2M | $-128.4M | $-116.9M | $-103.6M | $-94.8M | $-85.9M |
| Total Stockholders' Equity | $20.1M | $4.7M | $7.7M | $10.8M | $21.9M | $13.0M | $5.7M | $13.6M |